Victor Gurewich, MD, has spent more than two decades trying to spread the word about what he sees as an effective, lifesaving treatment approach to heart attack and stroke. At 88 years old, the cardiologist is hoping to breakthrough soon—and a new clinical trial in Europe could help.
In a lengthy story by STAT, Gurewich details his combination therapy that uses two medications to break up clots. He argues this approach could quickly open blocked vessels, to improve outcomes for stroke patients with less risk, while giving heart attack patients more time to undergo angioplasty.
“It’s all pretty obvious,” Gurewich said of his approach, because that’s how clots are naturally dissolved in the body. “What’s not so obvious is why it’s ignored.”
Read the full story here:
Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.